Nabi Biopharmaceuticals Announces Third Quarter 2008 Financial Results
06 nov. 2008 16h05 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three month period ended September 27, 2008. The...
Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
29 oct. 2008 09h25 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results On November 6, 2008
27 oct. 2008 15h00 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2008 financial results on Thursday, November 6, 2008,...
Nabi Biopharmaceuticals and NIAID to Advance PentaStaph Vaccine Research
09 sept. 2008 08h30 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), one of the National...
Nabi Biopharmaceuticals Announces Second Quarter 2008 Financial Results
07 août 2008 16h05 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 7, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 28, 2008. The Company...
Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.
04 août 2008 16h30 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., Aug. 4, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of an arbitration proceeding against Inhibitex, Inc., effective August 1, 2008....
Nabi Biopharmaceuticals to Announce Second Quarter Financial Results On August 7, 2008
29 juil. 2008 09h30 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 29, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2008 financial results on Thursday, August 7, 2008, after...
Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
23 juil. 2008 09h15 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., July 23, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive interim results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
Nabi Biopharmaceuticals Announces Receipt of $2.5 Million Milestone Payment
03 juin 2008 09h00 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., June 3, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has received a $2.5 million payment from Fresenius USA Manufacturing, Inc. (Fresenius) for the successful...
Nabi Biopharmaceuticals Announces First Quarter 2008 Financial Results
08 mai 2008 16h00 HE
|
Nabi Biopharmaceuticals
ROCKVILLE, Md., May 8, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 29, 2008. The Company...